%0 Journal Article
%A Schouten, Aniek E M
%A Hiensch, Anouk E
%A Frederix, Geert W J
%A Monninkhof, Evelyn M
%A Schmidt, Martina
%A Clauss, Dorothea
%A Gunasekara, Nadira
%A Belloso, Jon
%A Trevaskis, Mark
%A Rundqvist, Helene
%A Wiskemann, Joachim
%A Müller, Jana
%A Sweegers, Maike G
%A Fremd, Carlo
%A Altena, Renske
%A Bijlsma, Rhodé M
%A Sonke, Gabe
%A Lahuerta, Ainhara
%A Mann, G Bruce
%A Francis, Prudence A
%A Richardson, Gary
%A Malter, Wolfram
%A Kufel-Grabowska, Joanna
%A van der Wall, Elsken
%A Aaronson, Neil K
%A Senkus, Elzbieta
%A Urruticoechea, Ander
%A Zopf, Eva M
%A Bloch, Wilhelm
%A Stuiver, Martijn M
%A Wengstrom, Yvonne
%A Steindorf, Karen
%A van der Meulen, Miriam P
%A May, Anne M
%T Supervised Exercise for Patients With Metastatic Breast Cancer: A Cost-Utility Analysis Alongside the PREFERABLE-EFFECT Randomized Controlled Trial.
%J Journal of clinical oncology
%V 43
%N 11
%@ 0732-183X
%C Alexandria, Va.
%I American Society of Clinical Oncology
%M DKFZ-2025-00130
%P 1325-1336
%D 2025
%Z 2025 Apr 10;43(11):1325-1336
%X To evaluate the cost utility of a 9-month supervised exercise program for patients with metastatic breast cancer (mBC), compared with control (usual care, supplemented with general activity advice and an activity tracker). Evidence on the cost-effectiveness of exercise for patients with mBC is essential for implementation in clinical practice and is currently lacking.A cost-utility analysis was performed alongside the multinational PREFERABLE-EFFECT randomized controlled trial, conducted in 8 centers across Europe and Australia. Patients with mBC (N = 357) were randomly assigned to either a 9-month, twice-weekly, supervised exercise group (EG) or control group (CG). Costs of the exercise program were calculated through a bottom-up approach. Other health care resource use, productivity losses, and quality of life were collected using country-adapted, self-reported questionnaires. Analyses were conducted from a societal perspective with a time horizon of 9 months. Costs were collected and reported in 2021 Euros (€1 = 
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:39805062
%R 10.1200/JCO-24-01441
%U https://inrepo02.dkfz.de/record/296217